Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults
Phase 2
Not yet recruiting
- Conditions
- Asthma
- Interventions
- Other: Glycerin with Oxyquinoline SulfateDrug: Antipyrine-benzocaine otic solution
- First Posted Date
- 2014-06-03
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Global United Pharmaceutical Corporation
- Target Recruit Count
- 50
- Registration Number
- NCT02153541
- Locations
- 🇺🇸
Augusta University, Augusta, Georgia, United States
News
No news found